カテゴリー： LP Information, 世界, 部品/材料

世界の生理活性ペプチド市場予測 2023年-2029年

◆英語タイトル：Global Bio-active Peptides Market Growth 2023-2029
	◆商品コード：LP23JU5603 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：104 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の生理活性ペプチド市場」は、過去の販売実績から2022年の世界の生理活性ペプチドの総販売量を検討し、2023年から2029年の予測される生理活性ペプチドの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の生理活性ペプチドの市場規模を掲載し、XXX百万米ドル規模の世界の生理活性ペプチド市場の詳細な分析を提供します。本インサイトレポートは、世界の生理活性ペプチド業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の生理活性ペプチド市場における各社の独自のポジションをより深く理解するために、生理活性ペプチド製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の生理活性ペプチド市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。生理活性ペプチドの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。生理活性ペプチドの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。生理活性ペプチドのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

生理活性ペプチドの世界主要メーカーとしては、Archer Daniels Midland Company、 Seagarden AS、 Phermpep、 Arlak Biotech、 Naturade、 Royal DSM、 MYOS RENS Technology、 Natural Factors Nutritional Products、 Valio Oy、 Wuhan Lullaby Pharmaceutical Chemical、 Wuhan Dahua Pharmaceutical、 Pharma Foods Internationalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の生理活性ペプチド市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では生理活性ペプチド市場をセグメンテーションし、種類別 (天然生理活性ペプチド、人工合成生理活性ペプチド)、用途別 (食品、健康食品、医薬品、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：天然生理活性ペプチド、人工合成生理活性ペプチド

・用途別区分：食品、健康食品、医薬品、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の生理活性ペプチド市場の10年間の市場状況・展望は？
・世界および地域別に見た生理活性ペプチド市場成長の要因は何か？
・生理活性ペプチドの市場機会はエンドマーケットの規模によってどのように変化するのか？
・生理活性ペプチドのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：生理活性ペプチドの年間販売量2018-2029、地域別現状・将来分析
・生理活性ペプチドの種類別セグメント：天然生理活性ペプチド、人工合成生理活性ペプチド
・生理活性ペプチドの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・生理活性ペプチドの用途別セグメント：食品、健康食品、医薬品、その他
・生理活性ペプチドの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の生理活性ペプチド市場
・企業別のグローバル生理活性ペプチド市場データ：2018-2023年の年間販売量、市場シェア
・企業別の生理活性ペプチドの年間売上：2018-2023年の売上、市場シェア
・企業別の生理活性ペプチド販売価格
・主要企業の生理活性ペプチド生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

生理活性ペプチドの地域別レビュー
・地域別の生理活性ペプチド市場規模2018-2023：年間販売量、売上
・主要国別の生理活性ペプチド市場規模2018-2023：年間販売量、売上
・南北アメリカの生理活性ペプチド販売の成長
・アジア太平洋の生理活性ペプチド販売の成長
・ヨーロッパの生理活性ペプチド販売の成長
・中東・アフリカの生理活性ペプチド販売の成長

南北アメリカ市場
・南北アメリカの国別の生理活性ペプチド販売量、売上（2018-2023）
・南北アメリカの生理活性ペプチドの種類別販売量
・南北アメリカの生理活性ペプチドの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の生理活性ペプチド販売量、売上（2018-2023）
・アジア太平洋の生理活性ペプチドの種類別販売量
・アジア太平洋の生理活性ペプチドの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の生理活性ペプチド販売量、売上（2018-2023）
・ヨーロッパの生理活性ペプチドの種類別販売量
・ヨーロッパの生理活性ペプチドの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の生理活性ペプチド販売量、売上（2018-2023）
・中東・アフリカの生理活性ペプチドの種類別販売量
・中東・アフリカの生理活性ペプチドの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・生理活性ペプチドの製造コスト構造分析
・生理活性ペプチドの製造プロセス分析
・生理活性ペプチドの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・生理活性ペプチドの主要なグローバル販売業者
・生理活性ペプチドの主要なグローバル顧客

地域別の生理活性ペプチド市場予測レビュー
・地域別の生理活性ペプチド市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・生理活性ペプチドの種類別市場規模予測
・生理活性ペプチドの用途別市場規模予測

主要企業分析
Archer Daniels Midland Company、 Seagarden AS、 Phermpep、 Arlak Biotech、 Naturade、 Royal DSM、 MYOS RENS Technology、 Natural Factors Nutritional Products、 Valio Oy、 Wuhan Lullaby Pharmaceutical Chemical、 Wuhan Dahua Pharmaceutical、 Pharma Foods International
・企業情報
・生理活性ペプチド製品
・生理活性ペプチド販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
LPI (LP Information)’ newest research report, the “Bio-active Peptides Industry Forecast” looks at past sales and reviews total world Bio-active Peptides sales in 2022, providing a comprehensive analysis by region and market sector of projected Bio-active Peptides sales for 2023 through 2029. With Bio-active Peptides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bio-active Peptides industry.
This Insight Report provides a comprehensive analysis of the global Bio-active Peptides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bio-active Peptides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bio-active Peptides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bio-active Peptides and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bio-active Peptides.
The global Bio-active Peptides market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Bio-active Peptides is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bio-active Peptides is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bio-active Peptides is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bio-active Peptides players cover Archer Daniels Midland Company, Seagarden AS, Phermpep, Arlak Biotech, Naturade, Royal DSM, MYOS RENS Technology, Natural Factors Nutritional Products and Valio Oy, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Bio-active Peptides market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Natural Bio-active Peptides
Artificial Synthesis Bio-active Peptides
Segmentation by application
Food
Health Products
Pharmaceutical
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Archer Daniels Midland Company
Seagarden AS
Phermpep
Arlak Biotech
Naturade
Royal DSM
MYOS RENS Technology
Natural Factors Nutritional Products
Valio Oy
Wuhan Lullaby Pharmaceutical Chemical
Wuhan Dahua Pharmaceutical
Pharma Foods International
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bio-active Peptides market?
What factors are driving Bio-active Peptides market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bio-active Peptides market opportunities vary by end market size?
How does Bio-active Peptides break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bio-active Peptides Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bio-active Peptides by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bio-active Peptides by Country/Region, 2018, 2022 & 2029
2.2 Bio-active Peptides Segment by Type
2.2.1 Natural Bio-active Peptides
2.2.2 Artificial Synthesis Bio-active Peptides
2.3 Bio-active Peptides Sales by Type
2.3.1 Global Bio-active Peptides Sales Market Share by Type (2018-2023)
2.3.2 Global Bio-active Peptides Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bio-active Peptides Sale Price by Type (2018-2023)
2.4 Bio-active Peptides Segment by Application
2.4.1 Food
2.4.2 Health Products
2.4.3 Pharmaceutical
2.4.4 Other
2.5 Bio-active Peptides Sales by Application
2.5.1 Global Bio-active Peptides Sale Market Share by Application (2018-2023)
2.5.2 Global Bio-active Peptides Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bio-active Peptides Sale Price by Application (2018-2023)
3 Global Bio-active Peptides by Company
3.1 Global Bio-active Peptides Breakdown Data by Company
3.1.1 Global Bio-active Peptides Annual Sales by Company (2018-2023)
3.1.2 Global Bio-active Peptides Sales Market Share by Company (2018-2023)
3.2 Global Bio-active Peptides Annual Revenue by Company (2018-2023)
3.2.1 Global Bio-active Peptides Revenue by Company (2018-2023)
3.2.2 Global Bio-active Peptides Revenue Market Share by Company (2018-2023)
3.3 Global Bio-active Peptides Sale Price by Company
3.4 Key Manufacturers Bio-active Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bio-active Peptides Product Location Distribution
3.4.2 Players Bio-active Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bio-active Peptides by Geographic Region
4.1 World Historic Bio-active Peptides Market Size by Geographic Region (2018-2023)
4.1.1 Global Bio-active Peptides Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bio-active Peptides Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bio-active Peptides Market Size by Country/Region (2018-2023)
4.2.1 Global Bio-active Peptides Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bio-active Peptides Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bio-active Peptides Sales Growth
4.4 APAC Bio-active Peptides Sales Growth
4.5 Europe Bio-active Peptides Sales Growth
4.6 Middle East & Africa Bio-active Peptides Sales Growth
5 Americas
5.1 Americas Bio-active Peptides Sales by Country
5.1.1 Americas Bio-active Peptides Sales by Country (2018-2023)
5.1.2 Americas Bio-active Peptides Revenue by Country (2018-2023)
5.2 Americas Bio-active Peptides Sales by Type
5.3 Americas Bio-active Peptides Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bio-active Peptides Sales by Region
6.1.1 APAC Bio-active Peptides Sales by Region (2018-2023)
6.1.2 APAC Bio-active Peptides Revenue by Region (2018-2023)
6.2 APAC Bio-active Peptides Sales by Type
6.3 APAC Bio-active Peptides Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bio-active Peptides by Country
7.1.1 Europe Bio-active Peptides Sales by Country (2018-2023)
7.1.2 Europe Bio-active Peptides Revenue by Country (2018-2023)
7.2 Europe Bio-active Peptides Sales by Type
7.3 Europe Bio-active Peptides Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bio-active Peptides by Country
8.1.1 Middle East & Africa Bio-active Peptides Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bio-active Peptides Revenue by Country (2018-2023)
8.2 Middle East & Africa Bio-active Peptides Sales by Type
8.3 Middle East & Africa Bio-active Peptides Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bio-active Peptides
10.3 Manufacturing Process Analysis of Bio-active Peptides
10.4 Industry Chain Structure of Bio-active Peptides
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bio-active Peptides Distributors
11.3 Bio-active Peptides Customer
12 World Forecast Review for Bio-active Peptides by Geographic Region
12.1 Global Bio-active Peptides Market Size Forecast by Region
12.1.1 Global Bio-active Peptides Forecast by Region (2024-2029)
12.1.2 Global Bio-active Peptides Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bio-active Peptides Forecast by Type
12.7 Global Bio-active Peptides Forecast by Application
13 Key Players Analysis
13.1 Archer Daniels Midland Company
13.1.1 Archer Daniels Midland Company Company Information
13.1.2 Archer Daniels Midland Company Bio-active Peptides Product Portfolios and Specifications
13.1.3 Archer Daniels Midland Company Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Archer Daniels Midland Company Main Business Overview
13.1.5 Archer Daniels Midland Company Latest Developments
13.2 Seagarden AS
13.2.1 Seagarden AS Company Information
13.2.2 Seagarden AS Bio-active Peptides Product Portfolios and Specifications
13.2.3 Seagarden AS Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Seagarden AS Main Business Overview
13.2.5 Seagarden AS Latest Developments
13.3 Phermpep
13.3.1 Phermpep Company Information
13.3.2 Phermpep Bio-active Peptides Product Portfolios and Specifications
13.3.3 Phermpep Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Phermpep Main Business Overview
13.3.5 Phermpep Latest Developments
13.4 Arlak Biotech
13.4.1 Arlak Biotech Company Information
13.4.2 Arlak Biotech Bio-active Peptides Product Portfolios and Specifications
13.4.3 Arlak Biotech Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Arlak Biotech Main Business Overview
13.4.5 Arlak Biotech Latest Developments
13.5 Naturade
13.5.1 Naturade Company Information
13.5.2 Naturade Bio-active Peptides Product Portfolios and Specifications
13.5.3 Naturade Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Naturade Main Business Overview
13.5.5 Naturade Latest Developments
13.6 Royal DSM
13.6.1 Royal DSM Company Information
13.6.2 Royal DSM Bio-active Peptides Product Portfolios and Specifications
13.6.3 Royal DSM Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Royal DSM Main Business Overview
13.6.5 Royal DSM Latest Developments
13.7 MYOS RENS Technology
13.7.1 MYOS RENS Technology Company Information
13.7.2 MYOS RENS Technology Bio-active Peptides Product Portfolios and Specifications
13.7.3 MYOS RENS Technology Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MYOS RENS Technology Main Business Overview
13.7.5 MYOS RENS Technology Latest Developments
13.8 Natural Factors Nutritional Products
13.8.1 Natural Factors Nutritional Products Company Information
13.8.2 Natural Factors Nutritional Products Bio-active Peptides Product Portfolios and Specifications
13.8.3 Natural Factors Nutritional Products Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Natural Factors Nutritional Products Main Business Overview
13.8.5 Natural Factors Nutritional Products Latest Developments
13.9 Valio Oy
13.9.1 Valio Oy Company Information
13.9.2 Valio Oy Bio-active Peptides Product Portfolios and Specifications
13.9.3 Valio Oy Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Valio Oy Main Business Overview
13.9.5 Valio Oy Latest Developments
13.10 Wuhan Lullaby Pharmaceutical Chemical
13.10.1 Wuhan Lullaby Pharmaceutical Chemical Company Information
13.10.2 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product Portfolios and Specifications
13.10.3 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Wuhan Lullaby Pharmaceutical Chemical Main Business Overview
13.10.5 Wuhan Lullaby Pharmaceutical Chemical Latest Developments
13.11 Wuhan Dahua Pharmaceutical
13.11.1 Wuhan Dahua Pharmaceutical Company Information
13.11.2 Wuhan Dahua Pharmaceutical Bio-active Peptides Product Portfolios and Specifications
13.11.3 Wuhan Dahua Pharmaceutical Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Wuhan Dahua Pharmaceutical Main Business Overview
13.11.5 Wuhan Dahua Pharmaceutical Latest Developments
13.12 Pharma Foods International
13.12.1 Pharma Foods International Company Information
13.12.2 Pharma Foods International Bio-active Peptides Product Portfolios and Specifications
13.12.3 Pharma Foods International Bio-active Peptides Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Pharma Foods International Main Business Overview
13.12.5 Pharma Foods International Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Bio-active Peptides Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bio-active Peptides Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Natural Bio-active Peptides
Table 4. Major Players of Artificial Synthesis Bio-active Peptides
Table 5. Global Bio-active Peptides Sales by Type (2018-2023) & (Ton)
Table 6. Global Bio-active Peptides Sales Market Share by Type (2018-2023)
Table 7. Global Bio-active Peptides Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bio-active Peptides Revenue Market Share by Type (2018-2023)
Table 9. Global Bio-active Peptides Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Bio-active Peptides Sales by Application (2018-2023) & (Ton)
Table 11. Global Bio-active Peptides Sales Market Share by Application (2018-2023)
Table 12. Global Bio-active Peptides Revenue by Application (2018-2023)
Table 13. Global Bio-active Peptides Revenue Market Share by Application (2018-2023)
Table 14. Global Bio-active Peptides Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Bio-active Peptides Sales by Company (2018-2023) & (Ton)
Table 16. Global Bio-active Peptides Sales Market Share by Company (2018-2023)
Table 17. Global Bio-active Peptides Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bio-active Peptides Revenue Market Share by Company (2018-2023)
Table 19. Global Bio-active Peptides Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Bio-active Peptides Producing Area Distribution and Sales Area
Table 21. Players Bio-active Peptides Products Offered
Table 22. Bio-active Peptides Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bio-active Peptides Sales by Geographic Region (2018-2023) & (Ton)
Table 26. Global Bio-active Peptides Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bio-active Peptides Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bio-active Peptides Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bio-active Peptides Sales by Country/Region (2018-2023) & (Ton)
Table 30. Global Bio-active Peptides Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bio-active Peptides Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bio-active Peptides Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bio-active Peptides Sales by Country (2018-2023) & (Ton)
Table 34. Americas Bio-active Peptides Sales Market Share by Country (2018-2023)
Table 35. Americas Bio-active Peptides Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bio-active Peptides Revenue Market Share by Country (2018-2023)
Table 37. Americas Bio-active Peptides Sales by Type (2018-2023) & (Ton)
Table 38. Americas Bio-active Peptides Sales by Application (2018-2023) & (Ton)
Table 39. APAC Bio-active Peptides Sales by Region (2018-2023) & (Ton)
Table 40. APAC Bio-active Peptides Sales Market Share by Region (2018-2023)
Table 41. APAC Bio-active Peptides Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bio-active Peptides Revenue Market Share by Region (2018-2023)
Table 43. APAC Bio-active Peptides Sales by Type (2018-2023) & (Ton)
Table 44. APAC Bio-active Peptides Sales by Application (2018-2023) & (Ton)
Table 45. Europe Bio-active Peptides Sales by Country (2018-2023) & (Ton)
Table 46. Europe Bio-active Peptides Sales Market Share by Country (2018-2023)
Table 47. Europe Bio-active Peptides Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bio-active Peptides Revenue Market Share by Country (2018-2023)
Table 49. Europe Bio-active Peptides Sales by Type (2018-2023) & (Ton)
Table 50. Europe Bio-active Peptides Sales by Application (2018-2023) & (Ton)
Table 51. Middle East & Africa Bio-active Peptides Sales by Country (2018-2023) & (Ton)
Table 52. Middle East & Africa Bio-active Peptides Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bio-active Peptides Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bio-active Peptides Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bio-active Peptides Sales by Type (2018-2023) & (Ton)
Table 56. Middle East & Africa Bio-active Peptides Sales by Application (2018-2023) & (Ton)
Table 57. Key Market Drivers & Growth Opportunities of Bio-active Peptides
Table 58. Key Market Challenges & Risks of Bio-active Peptides
Table 59. Key Industry Trends of Bio-active Peptides
Table 60. Bio-active Peptides Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bio-active Peptides Distributors List
Table 63. Bio-active Peptides Customer List
Table 64. Global Bio-active Peptides Sales Forecast by Region (2024-2029) & (Ton)
Table 65. Global Bio-active Peptides Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bio-active Peptides Sales Forecast by Country (2024-2029) & (Ton)
Table 67. Americas Bio-active Peptides Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bio-active Peptides Sales Forecast by Region (2024-2029) & (Ton)
Table 69. APAC Bio-active Peptides Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bio-active Peptides Sales Forecast by Country (2024-2029) & (Ton)
Table 71. Europe Bio-active Peptides Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bio-active Peptides Sales Forecast by Country (2024-2029) & (Ton)
Table 73. Middle East & Africa Bio-active Peptides Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bio-active Peptides Sales Forecast by Type (2024-2029) & (Ton)
Table 75. Global Bio-active Peptides Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bio-active Peptides Sales Forecast by Application (2024-2029) & (Ton)
Table 77. Global Bio-active Peptides Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Archer Daniels Midland Company Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 79. Archer Daniels Midland Company Bio-active Peptides Product Portfolios and Specifications
Table 80. Archer Daniels Midland Company Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Archer Daniels Midland Company Main Business
Table 82. Archer Daniels Midland Company Latest Developments
Table 83. Seagarden AS Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 84. Seagarden AS Bio-active Peptides Product Portfolios and Specifications
Table 85. Seagarden AS Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Seagarden AS Main Business
Table 87. Seagarden AS Latest Developments
Table 88. Phermpep Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 89. Phermpep Bio-active Peptides Product Portfolios and Specifications
Table 90. Phermpep Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Phermpep Main Business
Table 92. Phermpep Latest Developments
Table 93. Arlak Biotech Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 94. Arlak Biotech Bio-active Peptides Product Portfolios and Specifications
Table 95. Arlak Biotech Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Arlak Biotech Main Business
Table 97. Arlak Biotech Latest Developments
Table 98. Naturade Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 99. Naturade Bio-active Peptides Product Portfolios and Specifications
Table 100. Naturade Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Naturade Main Business
Table 102. Naturade Latest Developments
Table 103. Royal DSM Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 104. Royal DSM Bio-active Peptides Product Portfolios and Specifications
Table 105. Royal DSM Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Royal DSM Main Business
Table 107. Royal DSM Latest Developments
Table 108. MYOS RENS Technology Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 109. MYOS RENS Technology Bio-active Peptides Product Portfolios and Specifications
Table 110. MYOS RENS Technology Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. MYOS RENS Technology Main Business
Table 112. MYOS RENS Technology Latest Developments
Table 113. Natural Factors Nutritional Products Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 114. Natural Factors Nutritional Products Bio-active Peptides Product Portfolios and Specifications
Table 115. Natural Factors Nutritional Products Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Natural Factors Nutritional Products Main Business
Table 117. Natural Factors Nutritional Products Latest Developments
Table 118. Valio Oy Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 119. Valio Oy Bio-active Peptides Product Portfolios and Specifications
Table 120. Valio Oy Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Valio Oy Main Business
Table 122. Valio Oy Latest Developments
Table 123. Wuhan Lullaby Pharmaceutical Chemical Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 124. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product Portfolios and Specifications
Table 125. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Wuhan Lullaby Pharmaceutical Chemical Main Business
Table 127. Wuhan Lullaby Pharmaceutical Chemical Latest Developments
Table 128. Wuhan Dahua Pharmaceutical Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 129. Wuhan Dahua Pharmaceutical Bio-active Peptides Product Portfolios and Specifications
Table 130. Wuhan Dahua Pharmaceutical Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Wuhan Dahua Pharmaceutical Main Business
Table 132. Wuhan Dahua Pharmaceutical Latest Developments
Table 133. Pharma Foods International Basic Information, Bio-active Peptides Manufacturing Base, Sales Area and Its Competitors
Table 134. Pharma Foods International Bio-active Peptides Product Portfolios and Specifications
Table 135. Pharma Foods International Bio-active Peptides Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Pharma Foods International Main Business
Table 137. Pharma Foods International Latest Developments
List of Figures
Figure 1. Picture of Bio-active Peptides
Figure 2. Bio-active Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bio-active Peptides Sales Growth Rate 2018-2029 (Ton)
Figure 7. Global Bio-active Peptides Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bio-active Peptides Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Natural Bio-active Peptides
Figure 10. Product Picture of Artificial Synthesis Bio-active Peptides
Figure 11. Global Bio-active Peptides Sales Market Share by Type in 2022
Figure 12. Global Bio-active Peptides Revenue Market Share by Type (2018-2023)
Figure 13. Bio-active Peptides Consumed in Food
Figure 14. Global Bio-active Peptides Market: Food (2018-2023) & (Ton)
Figure 15. Bio-active Peptides Consumed in Health Products
Figure 16. Global Bio-active Peptides Market: Health Products (2018-2023) & (Ton)
Figure 17. Bio-active Peptides Consumed in Pharmaceutical
Figure 18. Global Bio-active Peptides Market: Pharmaceutical (2018-2023) & (Ton)
Figure 19. Bio-active Peptides Consumed in Other
Figure 20. Global Bio-active Peptides Market: Other (2018-2023) & (Ton)
Figure 21. Global Bio-active Peptides Sales Market Share by Application (2022)
Figure 22. Global Bio-active Peptides Revenue Market Share by Application in 2022
Figure 23. Bio-active Peptides Sales Market by Company in 2022 (Ton)
Figure 24. Global Bio-active Peptides Sales Market Share by Company in 2022
Figure 25. Bio-active Peptides Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Bio-active Peptides Revenue Market Share by Company in 2022
Figure 27. Global Bio-active Peptides Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Bio-active Peptides Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Bio-active Peptides Sales 2018-2023 (Ton)
Figure 30. Americas Bio-active Peptides Revenue 2018-2023 ($ Millions)
Figure 31. APAC Bio-active Peptides Sales 2018-2023 (Ton)
Figure 32. APAC Bio-active Peptides Revenue 2018-2023 ($ Millions)
Figure 33. Europe Bio-active Peptides Sales 2018-2023 (Ton)
Figure 34. Europe Bio-active Peptides Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Bio-active Peptides Sales 2018-2023 (Ton)
Figure 36. Middle East & Africa Bio-active Peptides Revenue 2018-2023 ($ Millions)
Figure 37. Americas Bio-active Peptides Sales Market Share by Country in 2022
Figure 38. Americas Bio-active Peptides Revenue Market Share by Country in 2022
Figure 39. Americas Bio-active Peptides Sales Market Share by Type (2018-2023)
Figure 40. Americas Bio-active Peptides Sales Market Share by Application (2018-2023)
Figure 41. United States Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Bio-active Peptides Sales Market Share by Region in 2022
Figure 46. APAC Bio-active Peptides Revenue Market Share by Regions in 2022
Figure 47. APAC Bio-active Peptides Sales Market Share by Type (2018-2023)
Figure 48. APAC Bio-active Peptides Sales Market Share by Application (2018-2023)
Figure 49. China Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Bio-active Peptides Sales Market Share by Country in 2022
Figure 57. Europe Bio-active Peptides Revenue Market Share by Country in 2022
Figure 58. Europe Bio-active Peptides Sales Market Share by Type (2018-2023)
Figure 59. Europe Bio-active Peptides Sales Market Share by Application (2018-2023)
Figure 60. Germany Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Bio-active Peptides Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Bio-active Peptides Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Bio-active Peptides Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Bio-active Peptides Sales Market Share by Application (2018-2023)
Figure 69. Egypt Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Bio-active Peptides Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Bio-active Peptides in 2022
Figure 75. Manufacturing Process Analysis of Bio-active Peptides
Figure 76. Industry Chain Structure of Bio-active Peptides
Figure 77. Channels of Distribution
Figure 78. Global Bio-active Peptides Sales Market Forecast by Region (2024-2029)
Figure 79. Global Bio-active Peptides Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Bio-active Peptides Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Bio-active Peptides Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Bio-active Peptides Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Bio-active Peptides Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の生理活性ペプチド市場予測 2023年-2029年(Global Bio-active Peptides Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の生理活性ペプチド市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp